無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のバイオテクノロジー向け培地・血清・試薬市場

Global Markets for Media, Sera and Reagents in Biotechnology

発行 BCC Research 商品コード 237066
出版日 ページ情報 英文 199 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
世界のバイオテクノロジー向け培地・血清・試薬市場 Global Markets for Media, Sera and Reagents in Biotechnology
出版日: 2018年07月03日 ページ情報: 英文 199 Pages
担当者のコメント
市場規模、製品動向、企業シェアなどがバランスよく分析されております。数値データも豊富で、細胞培養関連ではベストセラーです。
概要

世界の細胞培養向け培地・血清・試薬市場は、2016年の約36億米ドルから、2021年までに46億米ドルまで拡大すると見られています。市場は、2016年〜2021年のCAGR (複合年間成長率) で、5.5%の成長が予測されています。

当レポートでは、世界のバイオテクノロジー向け培地・血清・試薬市場について調査分析し、市場・技術の概要、市場動向と予測、製品情報、産業構造、用途、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 市場・技術の背景

  • 専門用語
  • 細胞培養の発展における経緯
  • 細胞培養のタイプ
  • 細胞系、細胞株、形質転換細胞系
  • 細胞培養の汚染
  • 使用する試薬・材料の品質
  • 細胞培養の基本的要件

第4章 規制の側面

  • 生物学的製剤承認
  • 生物製剤の行政処分
  • リコール
  • その他の規制問題

第5章 新規開発

  • 細胞培養向けの新規開発

第6章 市場分析

  • 市場:種類別

第7章 産業構造

  • 培地
  • 血清
  • 試薬
  • 細胞培養市場のメーカー/サプライヤーの市場シェア

第8章 市場:エンドユーザー別

  • 世界の細胞培養市場:エンドユーザー別

第9章 特許分析

  • 年別
  • 種類別
  • 企業別
  • 国別
  • 譲受人別

第10章 現在の状況

  • 細胞培養市場の動向と問題点

第11章 企業プロファイル

付録:略語

BCC Researchについて

図表

List of Tables

  • Summary Table A: Global Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2023
  • Summary Table B: Global Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2023
  • Summary Table C: Global Market for Media, Sera and Reagents in Biotechnology, by Region, Through 2023
    • Table 1: Historic Background of Cell Culture Evolution, 1878-2016
    • Table 2: Comparison between Primary and Continuous Cell Line
    • Table 3: Antibiotics Used in Cell Culture Media
    • Table 4: Number of Biological License Application Approvals, 2010-2017
    • Table 5: Snapshot of Regenerative Product Pipeline
    • Table 6: Ethical Issues in Different Phases of Stem Cell Research
    • Table 7: Cell Characteristics Between 2D and 3D Cell Culture
    • Table 8: Global Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2023
    • Table 9: Global Market Share for Media, Sera and Reagents in Biotechnology, by Product Type, 2017
    • Table 10: Global Market for Media based on Serum Composition in Biotechnology, by Type, Through 2023
    • Table 11: Global Market Share for Media based on Serum Composition in Biotechnology, by Type, 2017
    • Table 12: Global Market for Media based on Physical State in Biotechnology, by Type, Through 2023
    • Table 13: Global Market Share for Media based on Physical State in Biotechnology, by Type, 2017
    • Table 14: Global Market for Media based on Composition in Biotechnology, by Type, Through 2023
    • Table 15: Global Market Share for Media based on Composition in Biotechnology, by Type, 2017
    • Table 16: Global Market for Sera in Biotechnology, by Type, Through 2023
    • Table 17: Global Market Share for Sera in Biotechnology, by Type, 2017
    • Table 18: Global Market for Reagents in Biotechnology, by Type, Through 2023
    • Table 19: Global Market Share for Reagents in Biotechnology, by Type, 2017
    • Table 20: Global Market for Biotechnology, by End User, Through 2023
    • Table 21: Global Market Share for Biotechnology, by End User, 2017
    • Table 22: Global Market for Media, Sera and Reagents in Biotechnology, by Region, Through 2023
    • Table 23: Global Market Share for Media, Sera and Reagents in Biotechnology, by Region, 2017
    • Table 24: North America Market for Media, Sera and Reagents in Biotechnology, by Country, Through 2023
    • Table 25: European Market for Media, Sera and Reagents in Biotechnology, by Country, Through 2023
    • Table 26: Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by Country, Through 2023
    • Table 27: Approvals of Biological License Applications, 2016-2018
    • Table 28: Biological Administrative Action Against Hct/P Manufacturer, 2016-2018
    • Table 29: Recalls, 2016-2018
    • Table 30: Recent Developments in the Cell Culture Industry, 2016-2018
    • Table 31: Number of Patents, by year, 2014-2016
    • Table 32: Number of Patents for Media, Sera and Reagents in Biotechnology, by Product Type, 2014-November 2016
    • Table 33: Number of Patents for Media, Sera and Reagents in Biotechnology, by Company, 2014-November 2016
    • Table 34: Number of Patents for Media, Sera and Reagents in Biotechnology, by Country Awarded, 2014-November 2016
    • Table 35: Number of Patents for Media, Sera and Reagents in Biotechnology, by Assignee Type, 2014-November 2016
    • Table 36: Global Market Share for Media, Sera and Reagents in Biotechnology, by Manufacturer, 2017
    • Table 37: Global Ranking of Manufacturers in Serum-free Media, 2017
    • Table 38: Global Ranking of Manufacturers in Serum-requiring Media, 2017
    • Table 39: Global Ranking of Manufacturers in Powdered Media, 2017
    • Table 40: Global Ranking of Manufacturers in Liquid Media, 2017
    • Table 41: Global Ranking of Manufacturers in Classical Media, 2017
    • Table 42: Global Ranking of Manufacturers in Specialty Media, 2017
    • Table 43: Global Ranking of Manufacturers in Sera, 2017
    • Table 44: Global Ranking of Manufacturers in the Reagents Markets, 2017
    • Table 45: Athena Environmental Sciences, Inc.: Cell Culture Product Portfolio
    • Table 46: Atlanta Biologicals: Cell Culture Product Portfolio
    • Table 47: BD Bioscience: Cell Culture Product Portfolio
    • Table 48: Biowest: Cell Culture Product Portfolio
    • Table 49: Bovogen Biologicals: Cell Culture Product Portfolio
    • Table 50: Cell Culture Technologies: Cell Culture Product Portfolio
    • Table 51: CellGenix: Cell Culture Product Portfolio
    • Table 52: Corning Incorporated: Cell Culture Product Portfolio
    • Table 53: Fujifilm Holdings Corp.: Cell Culture Product Portfolio
    • Table 54: GE Healthcare: Cell Culture Product Portfolio
    • Table 55: Gemini Bio-Products, Inc.: Cell Culture Product Portfolio
    • Table 56: Lonza: Cell Culture Product Portfolio
    • Table 57: Merck KGaA: Cell Culture Product Portfolio
    • Table 58: Miltenyi Biotec: Cell Culture Product Portfolio
    • Table 59: Peprotech, Inc.: Cell Culture Product Portfolio
    • Table 60: PromoCell: Cell Culture Product Portfolio
    • Table 61: Reprocell, Inc.: Cell Culture Product Portfolio
    • Table 62: Sartorius AG: Cell Culture Product Portfolio
    • Table 63: Takara Bio, Inc.: Cell Culture Product Portfolio
    • Table 64: Thermo Fisher Scientific, Inc.: Cell Culture Product Portfolio
    • Table 65: Abbreviations Used in Global Market for Media, Sera and Reagents in Biotechnology

List of Figures

  • Summary Figure A: Global Market for Media, Sera and Reagents in Biotechnology, by Product Type, 2017-2023
  • Summary Figure B: Global Market for Media, Sera and Reagents in Biotechnology, by End User, 2017-2023
  • Summary Figure C: Global Market for Media, Sera and Reagents in Biotechnology, by Region, 2017-2023
    • Figure 1: Global Market for Media, Sera and Reagents in Biotechnology, by Product Type, 2017-2023
    • Figure 2: Global Market for Media, Sera and Reagents in Biotechnology, by Type, 2017-2023
    • Figure 3: Global Market for Media based on Serum Composition in Biotechnology, by Type, 2017-2023
    • Figure 4: Global Market for Serum-free Media in Biotechnology, 2017-2023
    • Figure 5: Global Market for Serum-requiring Media in Biotechnology, 2017-2023
    • Figure 6: Global Market for Media based on Physical State in Biotechnology, by Type, 2017-2023
    • Figure 7: Global Market for Powdered Media in Biotechnology, 2017-2023
    • Figure 8: Global Market for Liquid Media in Biotechnology, 2017-2023
    • Figure 9: Global Market for Media based on Composition in Biotechnology, by Type, 2017-2023
    • Figure 10: Global Market Classical Media in Biotechnology, 2017-2023
    • Figure 11: Global Market for Specialty Media in Biotechnology, 2017-2023
    • Figure 12: Global Market for Sera in Biotechnology, by Type, 2017-2023
    • Figure 13: Global Market for Bovine Sera/Fetal Bovine Serum in Biotechnology, 2017-2023
    • Figure 14: Global Market for Other Sera in Biotechnology, 2017-2023
    • Figure 15: Global Market for Reagents in Biotechnology, by Type, 2017-2023
    • Figure 16: Global Market for Biological Response Modifiers (BRMs) in Biotechnology, 2017-2023
    • Figure 17: Global Market for Growth Factor in Biotechnology, 2017-2023
    • Figure 18: Global Market for Cytokine in Biotechnology, 2017-2023
    • Figure 19: Global Market for Other Biological Response Modifiers in Biotechnology, 2017-2023
    • Figure 20: Global Market for Cell Dissociation Reagents in Biotechnology, 2017-2023
    • Figure 21: Global Market for Other Reagents in Biotechnology, 2017-2023
    • Figure 22: Global Market for Biotechnology, by End User, 2017-2023
    • Figure 23: Global Market for Production Segment in Biotechnology, 2017-2023
    • Figure 24: Global Market for Research Segment in Biotechnology, 2017-2023
    • Figure 25: Global Market for Contract Segment in Biotechnology, 2017-2023
    • Figure 26: Global Market for Others Segment in Biotechnology, 2017-2023
    • Figure 27: Global Market for Media, Sera and Reagents in Biotechnology, by Region, 2017-2023
    • Figure 28: North America Market Share for Media, Sera and Reagents in Biotechnology, by Country, 2017
    • Figure 29: U.S. Market for Media, Sera and Reagents in Biotechnology, by Product Type, 2017-2023
    • Figure 30: Canada Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 31: Mexico Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 32: European Market Share for Media, Sera and Reagents in Biotechnology, by Country, 2017
    • Figure 33: German Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 34: U.K. Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 35: French Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 36: Italian Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 37: Spanish Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 38: Rest of Europe Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 39: Asia-Pacific Market Share for Media, Sera and Reagents in Biotechnology, by Country, 2017
    • Figure 40: Japanese Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 41: Chinese Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 42: Indian Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 43: Australia and New Zealand Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 44: Rest of Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 45: South America Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 46: Middle East and African Market for Media, Sera and Reagents in Biotechnology, 2017-2023
    • Figure 47: Number of Patents for Media, Sera and Reagents in Biotechnology, 2014-2016
    • Figure 48: Number of Patents for Media, Sera and Reagents in Biotechnology, by Product Type, 2014-November 2016
    • Figure 49: Number of Patents for Media, Sera and Reagents in Biotechnology, by Assignee Type, 2014-November 2016
    • Figure 50: Global Market Share for Media, Sera and Reagents in Biotechnology, by Manufacturer, 2017
    • Figure 51: Bio-Techne Corp.: Company Revenues, 2013-2017
    • Figure 52: Bio-Techne Corp.: Revenue Share, by Region, 2017
    • Figure 53: Bio-Techne Corp.: Revenue Share, by Business Unit, 2017
    • Figure 54: Becton, Dickinson and Company: Financial Performance, 2013-2017
    • Figure 55: Becton, Dickinson and Company: Revenue Share, by Business Unit, 2017
    • Figure 56: Becton, Dickinson and Company: Revenue Share, by Region, 2017
    • Figure 57: Corning Incorporated: Annual Revenue, 2014-2017
    • Figure 58: Corning Incorporated: Revenue Share, by Region, 2017
    • Figure 59: Corning Incorporated: Revenue Share, by Business Segment, 2017
    • Figure 60: Fujifilm Holdings Corp.: Annual Revenue, 2014-2017
    • Figure 61: Fujifilm Holdings Corp.: Revenue, by Region, 2017
    • Figure 62: GE Healthcare: Annual Revenue, 2013-2017
    • Figure 63: GE Healthcare: Revenue Share, by Business Unit, 2017
    • Figure 64: GE Healthcare: Revenue Share, by Region, 2017
    • Figure 65: GE Healthcare: Revenue Share, by Product Division, 2017
    • Figure 66: Lonza: Financial Performance, 2013-2017
    • Figure 67: Lonza: Revenue Share, by Business Unit, 2017
    • Figure 68: Merck KGaA: Annual Revenue, 2014-2017
    • Figure 69: Merck KGaA: Revenue Share, by Business Segment, 2017
    • Figure 70: Merck KGaA: Revenue Share, by Region, 2017
    • Figure 71: Sartorius AG: Annual Revenue, 2014-2017
    • Figure 72: Sartorius AG: Revenue Share, by Business Segment, 2017
    • Figure 73: Sartorius AG: Revenue Share, by Region, 2017
    • Figure 74: Takara Bio, Inc.: Financial Performance, 2013-2017
    • Figure 75: Takara Bio, Inc.: Revenue Share, by Business Unit, 2017
    • Figure 76: Takara Bio, Inc.: Revenue Share, by Region, 2017
    • Figure 77: Thermo Fisher Scientific, Inc.: Financial Performance, 2013-2017
    • Figure 78: Thermo Fisher Scientific, Inc.: Revenue Share, by Business Unit, 2017
    • Figure 79: Thermo Fisher Scientific, Inc.: Revenue Share, by Region, 2017
目次
Product Code: BIO014K

Highlights:

The global market for media, sera and reagents in biotechnology should reach $5.5 billion by 2023 from $4.1 billion in 2018 at a compound annual growth rate (CAGR) of 6.0% for the period 2018-2023.

The reagents segment of the global market for media, sera and reagents in biotechnology is expected to grow from $1.8 billion in 2018 to $2.4 billion in 2023 at a CAGR of 6.5% for the period 2018-2023.

The media segment of the global market for media, sera and reagents in biotechnology is expected to grow from $1.5 billion in 2018 to $2.1 billion in 2023 at a CAGR of 6.3% for the period 2018-2023.

Report Scope:

The current report provides detailed exposure of media, sera and reagents used in cell culture. This report highlights the current and future market potential of culture media, sera and reagents used in cell culture along with a detailed analysis of the competitive environment, regulatory scenario, and technological advancement, and patent analysis, drivers, restraints, opportunities and trends in market growth. The report also covers market projections to 2023 and market shares for key market players.

The report details market share of media, sera, and reagents in cell culture. Market analysis in the media segment is divided into specialty media and classical media based on composition. Based on formulation, the media are divided into powered media and ready-to-use liquid media. Based on serum component, media are segmented into serum-free media and serum-requiring media. The market for sera is segmented based on the source of serum into fetal bovine serum and other sera which includes sera from animal sources such as goats, porcines, rabbits, etc. The reagents market is segmented into reagents such as biological response modifiers, cell dissociation reagents, and others which includes amino acids, antibiotics, etc. By geography, the market has been segregated b North America, Europe, the Asia-Pacific region, Middle East and Africa, and South America. North America includes the U.S., Canada and Mexico, Europe includes Germany, U.K., France, Italy, Spain and Rest of Europe. The Asia-Pacific region includes China, India, Japan, Australia, New Zealand, and the Rest of Asia-Pacific.

For market estimates, data have been provided for 2017, estimated for 2018, and forecast for 2023.

Report Includes:

  • 36 data tables and 32 additional tables
  • Detailed overview and industry analysis of the global markets for media, sera and reagents used in cell culture within the biotechnology industry
  • Country specific data and analysis for United States, Canada, Mexico, Germany, U.K., France, China, India, Japan, Middle East and Africa
  • Quantification of market potential by various segments of the media, sera and reagents as well as composition formula, geographical regions and end users
  • Assessment of the market dynamics and elaboration on the influence of competitive environment, regulatory scenario, technological advancement, and the economic factors that are and will shape the marketplace
  • Information on different types of cell cultures and products from cell culture technology as well as the advantages and disadvantages for the use of various types of media
  • Discussion covering the applications of cell culture technology with an emphasis on usage in the research, production, and contract segments
  • Company profiles of major players in the industry, including Athena Environmental Science, Inc., Becton, Dickinson and Company, CellGenix, GE Healthcare, Lonza, and Thermo Fisher Scientific, Inc.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Market Definitions
    • Adherent Cell Culture
    • Carcinogenesis
    • Cell Culture
    • Cell Line
    • Continuous Cell Line
    • Cryopreservation
    • Culture Media
    • Eukaryotes
    • Finite Cell Lines
    • Mammalian Cell Line
    • Monolayer Sloughing
    • Mutagenesis
    • Osmolality
    • Phosphorylation
    • Prokaryotes
    • Serum
    • Subculture
    • Suspension Culture
    • Zwitterion
  • Historical Background of Cell Culture Evolution
  • Types of Cell Culture
    • Primary Culture
    • Secondary Culture
  • Morphology of Cells in Culture
  • Cell Culture Contaminations and Quality Controls
    • Cell Culture Contamination
    • Quality Controls in Cell Culture
  • Basic Components of Culture Media
    • Buffering Systems
    • Phenol Red
    • Inorganic Salts
    • Amino Acids
    • Carbohydrates
    • Proteins and Peptides
    • Fatty Acids and Lipids
    • Vitamins
    • Trace Elements
    • Media Supplements
    • Antibiotics
    • Serum
  • Application of Cell Culture

Chapter 4: Market Dynamics

  • Market Drivers
    • Growing Demand for Cell Culture Products from Biopharmaceutical Companies for the Production of Biologics and Biosimilars
    • Technological Advancements in Cell Culture & Growing Adoption Rates of Cell Culture-Based Vaccines
    • Remarkable Expansion of Cell Cultures Across a Wide Array of Applications
    • Rising Investment in R&D & Growing Demand for Regenerative Medicines
  • Market Restraints
    • Ethical Issues in Stem Cell Research & Regulatory Constraints on Biopharmaceuticals
    • Dearth of Skilled Technicians and Poor Infrastructure for Cell Culture Technology
  • Market Opportunities
    • Rising Demand for 3D Cell Cultures
    • Increase in Drug Discovery Activities and Growing CRO Markets in Emerging Economies

Chapter 5: Market Breakdown by Product Type

  • Global Market of Media, Sera and Reagents in Biotechnology, by Product Type
    • Market Analysis
    • Market Revenue
  • Media
    • Market Analysis
    • Market Revenue
    • Serum-free Media and Serum-requiring Media
    • Powdered and Liquid Media
    • Classical Media and Specialty Media
  • Sera
    • Market Analysis
    • Market Revenue
    • Bovine Sera/Fetal Bovine Serum
    • Other Sera
  • Reagents
    • Market Analysis
    • Market Revenue
    • Biological Response Modifiers (BRMs)
    • Cell Dissociation Reagents
    • Other Reagents

Chapter 6: Market Breakdown by End User

  • Global Market for Media, Sera and Reagents in Biotechnology, by End Users
  • Production Segment
    • Market Analysis
    • Market Revenue
  • Research Segment
    • Market Analysis
    • Market Revenue
  • Contract Segment
    • Market Analysis
    • Market Revenue
  • Others Segment
    • Market Analysis
    • Market Revenue

Chapter 7: Market Breakdown by Region

  • Global Market for Media, Sera and Reagents in Biotechnology, by Region
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific Region
    • Japan
    • China
    • India
    • Australia and New Zealand
    • Rest of Asia-Pacific
  • South America
  • Middle East & Africa

Chapter 8: Regulatory Scenarios

  • Introduction
  • Biological License Applications
  • Biological Administrative Actions
    • Recall
  • Sera-Regulatory Scenario

Chapter 9: Recent Technological Advancements in the Cell Culture Industry

Chapter 10: Patent Analysis

  • Patents by Year
  • Patents by Type
  • Patents by Company
  • Patents by Country
  • Patents by Assignee

Chapter 11: Industry Structure

  • Market Players and Market Structure Analysis
  • Media
    • Serum-free Media
    • Serum-requiring Media
    • Powdered Media
    • Liquid Media
    • Classical Media
    • Specialty Media
  • Sera
  • Reagents

Chapter 12: Company Profiles

  • ATHENA ENVIRONMENTAL SCIENCES, INC.
    • Company Overview
    • Product Portfolio
  • ATLANTA BIOLOGICALS (BIO-TECHNE CORP.)
    • Company Overview
    • Financials
    • Product Portfolio
    • Development and Strategies
  • BECTON, DICKINSON AND COMPANY
    • Company Overview
    • Financials
    • Product Portfolio
    • Development and Strategies
  • BIOWEST
    • Company Overview
    • Product Portfolio
    • Development and Strategies
  • BOVOGEN BIOLOGICALS PTY LTD.
    • Company Overview
    • Product Portfolio
  • CELL CULTURE TECHNOLOGIES
    • Company Overview
    • Product Portfolio
    • Development and Strategies
  • CELLGENIX GMBH
    • Company Overview
    • Product Portfolio
    • Development and Strategies
  • CORNING INCORPORATED
    • Company Overview
    • Financials
    • Product portfolio
    • Development and Strategies
  • FUJIFILM HOLDINGS CORP.
    • Company Overview
    • Financials
    • Product Portfolio
    • Development and Strategies
  • GE HEALTHCARE
    • Company Overview
    • Financials
    • Product Portfolio
    • Development and Strategies
  • GEMINI BIO-PRODUCTS, INC.
    • Company Overview
    • Product Portfolio
  • LONZA
    • Company Overview
    • Financials
    • Product Portfolio
    • Development and Strategies
  • MERCK KGAA
    • Company Overview
    • Financials
    • Product Portfolio
    • Development and Strategies
  • MILTENYI BIOTEC
    • Company Overview
    • Product Portfolio
  • PEPROTECH, INC.
    • Company Overview
    • Product Portfolio
  • PROMOCELL GMBH
    • Company Overview
    • Product Portfolio
    • Development and Strategies
  • REPROCELL, INC.
    • Company Overview
    • Product Portfolio
    • Development and Strategies
  • SARTORIUS AG
    • Company Overview
    • Financials
    • Product portfolio
    • Development and Strategies
  • TAKARA BIO, INC.
    • Company Overview
    • Financials
    • Product Portfolio
    • Development and Strategies
  • THERMO FISHER SCIENTIFIC, INC.
    • Company Overview
    • Financials
    • Product Portfolio
    • Development and Strategies

Chapter 13: Appendix: Abbreviations

Back to Top